financetom
Business
financetom
/
Business
/
Terex Q2 Earnings, Revenue Decline; 2024 Guidance Revised -- Shares Fall
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Terex Q2 Earnings, Revenue Decline; 2024 Guidance Revised -- Shares Fall
Jul 30, 2024 2:50 PM

05:28 PM EDT, 07/30/2024 (MT Newswires) -- Terex ( TEX ) reported Q2 earnings late Tuesday of $2.08 per diluted share, down from $2.34 a year earlier.

Analysts polled by Capital IQ expected $2.05.

Net Sales for the quarter ended June 30 was $1.38 billion down from $1.40 billion a year earlier. Analysts surveyed by Capital IQ expected $1.43 billion.

The company raised its 2024 earnings outlook to $7.15 to $7.45 from $6.95 to $7.35. Analysts polled by Capital IQ expected $7.09.

For 2024, the company lowered its net sales guidance between $5.1 billion and $5.3 billion from $5.2 billion and $5.4 billion. Analysts surveyed by Capital IQ expected $5.26 billion.

Shares fell more than 5% in recent after-hours activity.

Price: 61.99, Change: -3.71, Percent Change: -5.65

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Globe Life defends business model after short-seller criticism
Globe Life defends business model after short-seller criticism
Apr 4, 2024
April 4 (Reuters) - Globe Life ( GL ) touted its sustainable earnings growth on Thursday, a day after short-seller Nate Koppikar described the insurer as an attractive potential target for shortselling. For over 70 years our business model has stood the test of time, a Globe Life ( GL ) spokesperson said, adding that the articles Koppikar had referenced...
Soleno Therapeutics Insider Sold Shares Worth $784,645, According to a Recent SEC Filing
Soleno Therapeutics Insider Sold Shares Worth $784,645, According to a Recent SEC Filing
Apr 4, 2024
07:24 AM EDT, 04/04/2024 (MT Newswires) -- Bhatnagar Anish, Director, CHIEF EXECUTIVE OFFICER, on April 01, 2024, sold 18,980 shares in Soleno Therapeutics ( SLNO ) for $784,645. Following the Form 4 filing with the SEC, Anish has control over a total of 152,790 shares of the company, with 152,790 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1484565/000141588924010241/xslF345X03/form4-04042024_010415.xml ...
Market Chatter: PepsiCo Products Returns to Carrefour Stores in France
Market Chatter: PepsiCo Products Returns to Carrefour Stores in France
Apr 4, 2024
07:25 AM EDT, 04/04/2024 (MT Newswires) -- PepsiCo's ( PEP ) Pepsi and Cheetos products are available again at Carrefour stores in France as the companies have resolved pricing issues, The Wall Street Journal reported Wednesday, citing a statement from the companies and an unnamed source familiar with the matter. Carrefour had stopped carrying certain PepsiCo ( PEP ) snack...
Kits Eyecare Reporting Preliminary Q1 Results
Kits Eyecare Reporting Preliminary Q1 Results
Apr 4, 2024
07:24 AM EDT, 04/04/2024 (MT Newswires) -- Kits Eyecare Ltd. ( KTYCF ) on Thursday reported selected preliminary unaudited results for its first quarter ended March 31. The company said the first-quarter revenue rose to more than $34 million, reflecting a 23% year-over-year increase and a 7% increase sequentially. Also, the company said it ended the quarter with a healthy...
Copyright 2023-2026 - www.financetom.com All Rights Reserved